ALB and non-small cell lung carcinoma: There are many advantages of albumin NPs to facilitate their clinical applications and the development of clinically approved albumin-related formulations, Abraxane (Paclitaxel albumin nanoparticles approved for metastatic breast cancer, non-small cell lung cancer, and pancreas adenocarcinoma) is the most excellent example [12].